Neuronal c-Jun is required for successful axonal regeneration, but the effects of phosphorylation of its N-terminus are moderate. by Ruff, CA et al.
Transection of peripheral nerves or their axons (axotomy)
usually results in successful regeneration, by a part of the
axon still connected to its cell body growing back to
and reinnervating the peripheral target (Lieberman 1971;
Kreutzberg 1996). Recent studies using transgenic animal
models and viral vectors have demonstrated important
regeneration-promoting roles for several newly expressed
cell adhesion molecules (Werner et al. 2000; Hiroi et al.
2003, Makwana et al. 2009), neurotrophic and growth factor
signals (English et al. 2011; Makwana et al. 2009) and
neuropeptides (Sachs et al. 2007). The fact that many of
these molecular changes occur at the same time following
injury has focused interest on axotomy-induced transcription
factors that may orchestrate this regenerative response.
Deletion of CCAAT enhancer binding protein (cEBP) beta,
cEBP delta, sox11 and signal transducer and activator of
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Abstract
Although neural c-Jun is essential for successful peripheral nerve
regeneration, the cellular basis of this effect and the impact of c-
Jun activation are incompletely understood. In the current study,
we explored the effects of neuron-selective c-Jun deletion, sub-
stitution of serine 63 and 73 phosphoacceptor sites with non-
phosphorylatable alanine, and deletion of JunN-terminal kinases
1, 2 and 3 in mouse facial nerve regeneration. Removal of the
floxed c-jun gene in facial motoneurons using cre recombinase
under control of a neuron-specific synapsin promoter (junDS)
abolished basal and injury-induced neuronal c-Jun immunore-
activity, as well as most of the molecular responses following
facial axotomy. Absence of neuronal Jun reduced the speed of
axonal regeneration following crush, and prevented most cut
axons from reconnecting to their target, significantly reducing
functional recovery. Despite blocking cell death, this was asso-
ciated with a large number of shrunken neurons. Finally, junDS
mutants also had diminished astrocyte and microglial activation
and T-cell influx, suggesting that these non-neuronal responses
depend on the release of Jun-dependent signals from neigh-
boring injured motoneurons. The effects of substituting serine 63
and 73 phosphoacceptor sites (junAA), or of global deletion of
individual kinases responsible for N-terminal c-Jun phosphory-
lation were mild. junAA mutants showed decrease in neuronal
cell size, a moderate reduction in post-axotomy CD44 levels and
slightly increased astrogliosis. Deletion of Jun N-terminal kinase
(JNK)1 or JNK3 showed delayed functional recovery; deletion of
JNK3 also interfered with T-cell influx, and reduced CD44 levels.
Deletion of JNK2hadnoeffect. Thus, neuronal c-Jun is needed in
regeneration, but JNK phosphorylation of the N-terminus mostly
appears to not be required for its function.
Keywords: brain repair, peripheral nerve regeneration,
phosphorylation, transcription factor.
J. Neurochem. (2012) 121, 607–618.
JOURNAL OF NEUROCHEMISTRY | 2012 | 121 | 607–618 doi: 10.1111/j.1471-4159.2012.07706.x
 2012 The Authors
Journal of Neurochemistry  2012 International Society for Neurochemistry, J. Neurochem. (2012) 121, 607–618 607
transcription (STAT)3 has been associated with a reduction
in the initiation of axonal outgrowth and/or functional
recovery (Nadeau et al. 2005; Jankowski et al. 2009;
Magoulas and Lopez De Heredia 2010; Bareyre et al.
2011). The effects were particularly pronounced with
brain-wide deletion of c-Jun, which prevented the up-
regulation of axotomy-associated molecules (CD44, alpha7-
beta1 integrin, galanin), decreased successful reconnection to
peripheral targets by 4- to 5-fold, and strongly reduced
functional recovery (Raivich et al. 2004). Interestingly, cre
recombinase-mediated deletion of floxed c-Jun was also
associated with enhanced neuronal post-axotomy survival,
but of severely shrunken motoneurons. Because this cre
recombinase was driven by the nestin-promoter, expressed in
early neuroepithelial cells giving rise to neurons, astrocytes
or oligodendroglia, as well as in Schwann cell precursors, it
is still unclear whether the effects observed in neuronal
regeneration were due to its absence in neurons or other
nestin+ progenitor-derived cells (Rao 1999; Akiyama et al.
2001; Kanu et al. 2010).
The activator protein 1 (AP1) transcription complex is a
well-characterized regulator of neural development and
response to trauma, excitotoxic or hypoxic-ischemic injury
and consists of homo- or heterodimeric complexes between
members of the Jun, c-Fos and activating transcription factor
(ATF)/cyclic adenosine monophosphate (AMP) response
element-binding protein (CREB) families (Angel and Karin
1992). Its primary component, c-Jun, is produced as an
immediate early gene following nerve injury and persists at
high levels during the entire peripheral regenerative process
(Herdegen et al. 1991; Jenkins and Hunt 1991). With the
exception of retinal ganglion cell neurons (Herdegen et al.
1993; Koistinaho et al. 1993), up-regulation of c-Jun is either
transient or absent following transection of central fibers, and
may contribute to the reduced ability of centrally injured
neurons to regenerate (Anderson et al. 1998). Activation of
the c-Jun mediated transcription apparatus is affected by
interactions at three major sites: (i) N-terminal phosphory-
lation at Ser 63 and 73 and Thr 91 and 93 (Smeal et al. 1994;
Morton et al. 2003) and the ensuing ubiquitination and
degradation (Nateri et al. 2004), (ii) dephosphorylation of
Thr239 (Morton et al. 2003) and (iii) the C-terminal lysine
acetylation near aa257–276 (Vries et al. 2001). The best
studied is N-terminal phosphorylation through Jun N-termi-
nal kinases 1, 2 and 3 (JNK1–3), which can alter AP1
binding activity in the absence of de novo protein synthesis
(De´rijard et al. 1994; Kallunki et al. 1994). These JNK
mitogen-activated protein kinases are rapidly activated
following peripheral nerve injury and increase the amount
of phospho-c-Jun in the process (Waetzig et al. 2006).
Depending on the type of neural injury, deletion of JNK1, 2
and 3 has been shown to a prodegenerative or protective
effect (Pirianov et al. 2007; Haeusgen et al. 2009). Removal
of serine 63 and 73 phosphoacceptor sites in the junAA
mutant also interferes with exitotoxicity (Behrens et al.
1999), but relatively little is known about their involvement
in axotomy response and neurite outgrowth in vivo. In the
current study, we therefore examined the function, cellular
basis and possible activation of c-Jun in peripheral regener-
ation, using mutants with neuron-specific deletion of c-Jun,
global deletion of JNK1, 2 or 3, and alanine replacement of
the serine 63 and 73 sites.
Materials and methods
Animals, surgical procedures and tissue treatment
Mice carrying floxed c-jun allele (junF/F) (Behrens et al. 2002) were
crossed with syn::cre animals expressing cre recombinase under the
control of the synapsin promoter syn::cre (Zhu et al. 2001), twice, to
obtain homozygous CNS neuron-specific deletion of jun (junDS). To
prevent germline c-jun deletion due to testicular synapsin promoter
expression (Hoesche et al. 1993; Street et al. 2005), only female
cre+ mice (syn::cre junF/F) and cre- junF/F males were used for
breeding, generating junDS mutants and junF/F littermate controls
with normal Mendelian frequency. Homozygous JunAA, with serine
63 and 73 residues replaced with alanine (A) (Behrens et al. 1999)
and wild-type (wt) mice were derived as offspring of heterozygous
(AA/wt) breeder pairs. JNK1, 2 and 3 null mouse strains (Yang
et al. 1997; Dong et al. 1998; Kuan et al. 1999) were crossed with
C57Bl/6 mice, to obtain F1 heterozygotes, and in the second step,
the F2 homozygote and wild-type breeder pairs that were used to
generate mutants and their controls as described in detail elsewhere
(Brecht et al. 2005).
Mutant and wild-type controls 8–10 weeks old were anesthetised
with 10 lg/g 2,2,2-tribromoethanol (Sigma, Dorset, UK), the right
facial nerve was either crushed (for the day 4 time point) or cut for
all other time points at the stylomastoid foramen, and the animals
killed after 4–30 days with an overdose of Euthatal. The animals
were first perfused as described by Moller et al. (1996) with 150 mL
phosphate-buffered saline (PBS) followed by 200 mL of 4%
paraformaldehyde in PBS, 2 h post-fixed with 1% paraformalde-
hyde in PBS, cryoprotected in 30% sucrose in PBS and then frozen
on dry ice. The immunohistochemical methods, assessment of
axonal regeneration and functional recovery, retrograde tracing and
quantification of neuronal survival were performed as previously
(Moller et al. 1996; Raivich et al. 1998, 2002, 2004) and described
in detail in the Methods section of the Supplementary material.
Results
Generation of mutant mice
Cell type specific c-jun gene deletion was achieved by
crossing mice with a floxed c-jun allele (junF/F) with animals
expressing cre recombinase under the control of the synapsin
promoter (syn::cre), which targets the junDS recombination
specifically to neurons (Ku¨gler et al. 2001; Zhu et al. 2001).
Homozygous JunAA and wild-type (wt) mice were derived
as offspring of heterozygous (AA/wt) breeder pairs. JNK1, 2
and 3 knockout mice and their controls were produced from
F2 homozygous breeder pairs derived from heterozygous
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mice on C57Bl/6 background. All mutants used in the
current study displayed normal brain structure and histology
on H&E and NeuN stains on forebrain (cortex, hippocampus,
basal ganglia) and hind-brain (cerebellum, metencephalon)
sections (not shown). Homozygous junDS recombination
was associated with disappearance of basal immunoreactivity
throughout the brain, for example in hippocampus and
dentate gyrus (Fig. 1a and b), or the uninjured facial motor
nucleus (Fig. 1c and d). Motoneuron c-Jun immunoreactivity
is strongly up-regulated by facial nerve cut (Fig. 1f) and this
increase was abolished in the junDS mutant (Fig. 1e).
Previous study from our groups revealed the disappearance
of phospho-serine63 immunoreactivity in the neuronal nuclei
of the axotomized facial motor nucleus in junAA mice but
also a persistence of phosphoserine 73-like and as well as of
total c-Jun immunoreactivity. In the same study, single JNK
deletions were not associated with changes in overall
phospho-Jun immunoreactivity (Brecht et al. 2005). This
persistence of total c-Jun immunoreactivity in neuronal
nuclei of the axotomized facial motor nucleus in the junAA
mice was also reconfirmed in the current study (data not
shown).
Deletion of neuronal c-jun interferes with axonal
regeneration
Effects on axonal regeneration after facial nerve axotomy at
the stylomastoid foramen were assessed by the extent of
functional recovery, reinnervation of peripheral target, and
speed of axonal elongation in the early phase of nerve
regeneration. Functional recovery after facial nerve cut was
scored by observed whisker hair movement from 0 (no
movement) to 3 (strong, normal movement on uninjured side)
by two observers unaware of the animal genotype three times
per week for 28 days. As shown in Fig. 2a, junF/F animals
commenced recovery of whisker vibrissae at 12 days and
improved steadily over the next 2.5 weeks to day 28.
Recovery in homozygous junDS mutants was significantly
delayed (p < 0.01 in unpaired t-test, unless indicated, all
further tests are also unpaired t-test); first noticed at day 19, it
then improved but with a less steep trajectory than in the junF/
F mice. These differences were mirrored by changes in the
regeneration index, calculated as area under the curve for the
functional recovery over days 0–28 (Fig. 2b); with an index of
1.00 ± 0.04 for the junF/F (n = 5 animals) and 0.44 ± 0.02 for
the junDS mutants (n = 6 animals, p < 0.001).
To determine whether this defect was due to lack of axonal
reinnervation or simply reduced function of successfully
reinnervated axons, a gelfoam insert soaked with fluorescent
tracer Fluorogold (FG) was implanted for 30 min under both
whisker pads 28 days after facial nerve cut. The contralateral
whisker pad served as an intra-animal, uninjured control.
This was followed by 48 h of recovery and retrograde
transport to the facial nucleus, and then by perfusion,
freezing the brainstem and cutting through the whole
brainstem at the level of the facial motor nuclei. The
distribution of FG-labelled motoneurons on the the previ-
ously uninjured and on the injured side is shown in
Fig. 2c,d,g and h. Counting every fifth 20 um section,
junF/F animals (n = 5) revealed 168 ± 10 FG+ motoneurons
on the uninjured and 57 ± 5 on the injured side. Homozy-
gous junDS mutants (n = 6) also showed a very similar
number (173 ± 9) on the control side, but there was a very
drastic reduction on the axotomized side, with just 7 ± 2
FG+ motoneurons (Fig. 1e, p < 0.001). In relative terms (as
percent of contralateral side) junF/F animals showed retro-
grade labelling of 32.9 ±4.4%, and junDS mutants a more
than 8-fold decrease with 3.8% ± 1.1% (Fig. 1f, p < 0.001),
exceeding the defect in functional recovery.
As a next step, we explored whether these defects can be
attributed to lack of activation of Jun protein function (as
opposed to one that is simply absent) by performing these
experiments in phosphorylation-deficient homozygous mu-
tants lacking N-terminal phosphoacceptor sites serine-63 and
73 (junAA), or Jun N-terminal Kinases 1, 2 or 3 (JNK1–3),
following them for up to 50 days after facial nerve cut. In the
case of JunAA (Fig. 3a and b), functional recovery in




Fig. 1 Synapsin::cre deletion of floxed c-jun (junDS) removes c-Jun
immunoreactivity in normal brain and following facial nerve cut. (a, b)
Hippocampus, (c, d) uninjured facial motor nucleus, (e, f) facial nu-
cleus 14 days after facial nerve cut. Micrographs on the left (a, c, e)
show the junDS mutants, those on the right (b, d, f) the control, junF/F
animals. Note the strong c-Jun immunoreactivity on the right, in the
junF/F hippocampus and hippocampal dentate gyrus (hip and dg), as
well as in the large motoneuron nuclei of the facial nucleus (d, f),
particularly following nerve injury (f). Scale bar: 0.2 mm.
 2012 The Authors
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wild-type controls, with the only significant difference
(p < 0.05) at 12 days following facial nerve cut. Homozy-
gous deletion of JNK2 (Fig. 3i and j) had no significant
effect. In contrast, deletion of JNK1 (Fig. 3e and f) and
JNK3 (Fig. 3m and n) showed a significant delay in
functional recovery at different time points after nerve cut.
Similar effects were also observed for the regeneration index,
with significant reduction for JNK1 (Fig. 3f, p < 0.02) and a
similar trend for JNK3 (Fig. 3n, p = 0.074).
To see whether these defects were matched by a deficit in
target reinnervation, we next determined the extent of 48 h
retrograde transport of Fluorogold, 50 days after facial nerve
cut. However, as shown for junAA in Fig. 3c and d, for JNK1
in Fig. 3g and h, for JNK2 in Fig. 3k and l and for JNK3 in
Fig. 3o and p, all 4 mutants revealed reconnection rates that
were very similar to those for their wild-type controls.
As functional recovery following nerve cut depends on the
gradual formation of a non-neuronal cellular bridge between
the proximal and distal nerve stump and could be affected by
JNK deletions, we also examined the extent of early nerve
fibre outgrowth following facial nerve crush, where, despite
axotomy, the basal lamina scaffolds remain intact. The
growth front of the regenerating motor neurites 4 days after
facial nerve crush was quantified in longitudinal facial nerve
sections of 10 um thickness using immunoreactivity for the
calcitonin gene related peptide (CGRP) and galanin neuro-
peptides expressed in axotomized facial motoneurons (Wer-
ner et al. 2000). As shown in Fig. 4a, in the junF/F control
animals’ axonal growth front advanced to 5.8 ± 0.1 mm for
CGRP- and to 5.4 ± 0.2 mm for the galanin-positive axons.
In junDS mutants, this axonal elongation was reduced by
approx. 60% for both types of neuropeptide containing axons
(p < 0.0001). In contrast to junDS, homozygous deletion of
JNK1 (Fig. 4c), JNK2 (Fig. 4d) or JNK3 (Fig. 4e) did not
affect the extent of axonal elongation, compared with their
wild-type controls. Similar lack of effect on early phase of
regeneration following nerve crush was also observed for
junAA (Fig. 4b).
Neuronal c-Jun deletion abolishes neuronal cell loss after
nerve cut but affected motoneurons show atrophic
phenotype
Facial axotomy is normally associated with the cell death of
20–40% of lesioned motoneurons within 30 days after nerve
cut (Raivich et al. 2002) and pan-CNS deletion of c-Jun has
been shown to interfere with this process (Raivich et al.
2004). Figure S1a–f shows the effects of neuron-specific
deletion of jun on the Nissl stained sections of control
(Figure S1a and c) and axotomized (Figure S1b and d–f)
facial motor nuclei. After facial nerve cut, junF/F control
animals showed a pronounced loss of neurons (Figure S1b),
an effect lost in the junDS mutants. However, many of the
axotomized junDS motoneurons appeared shrunken and with
much paler Nissl staining (Figure S1d, compare also Fig-
ure S1e and f). Counting motoneuron profiles on the
uninjured and injured side throughout the facial motor
nucleus revealed a 38 ± 5% loss in junF/F controls, compared





Fig. 2 Neuronal c-Jun is required for successful functional recovery
and target reinnervation after facial nerve axotomy. (a, b) Time
course for functional recovery of whisker hair movement on the scale
from 0 (no movement) to 3 (full movement, equivalent to uninjured
side) (a) and the recovery index (b) calculated as area under the
curve (AUC) show pronounced reduction and delay in recovery junDS
mice (n = 6 mice) compared with the junF/F controls (n = 5 mice).
*p < 0.05 in unpaired t-test, bars and error bars in these and all
following graphs show the mean and SEM, respectively. In panel (a),
the significance levels were adjusted for multiple testing using Bon-
ferroni correction. (c–h) Peripheral target (whisker pad) reinnervation
using 48 h retrograde transport of FluoroGold to facial motor nucleus
30 days after nerve cut. (c, d, g, h) Micrographs showing FluoroGold
labelling on the contralateral control (co; c, g) and axotomized side
(ax; d, h). Retrograde labelling on the uninjured side is confined to a
discrete facial subnucleus (c, g); after injury, motoneurons reinner-
vating the whisker pad are found throughout the facial nucleus (f). (e,
f) Number of retrogradely labelled, counted motoneurons on the
contralateral and axotomized side (e) and the axotomized/control
side ratio (f). Neuronal deletion of c-Jun is associated with a more
than 8-fold decrease in whiskerpad reinnervation (c, d and arrow
in h).
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However, opposite effects were observed on cell size
(Figure S1m): in junF/F controls, average neuronal cell
diameter showed a trend towards increase on the axotomized
side, from 21.5 ± 0.7 um for the uninjured to 23.2 ± 0.8 um
for injured motoneurons (p = 0.085), the junDS mice a
decrease from 22.1 ± 0.3 to 15.5 ± 0.8 um (p < 0.005).
Compared with controls, the junAA mutants exhibited no
effect on neuronal loss (33% ± 8% vs. 35% ± 2% for control
and mutant mice, see Figure S1j), but still a significant
14 ± 2% decrease in neuronal size 30 days after facial nerve
cut (p < 0.05, Figure S1n). Deletion of JNK1 or JNK3 was
not associated with changes in neuronal loss (Figure S1k and
l) or neuronal cell size (Figure S1o and p, respectively).
Neuronal molecular response to injury depends on
neuronal c-Jun
In neurons capable of regeneration, axonal injury engenders
a switch to a regeneration programme comprising of
transcription factor changes, followed by adhesion mole-
cules, neuropeptides and growth factor signalling, and an
Fig. 3 (a–c, e–g, i–k, m–o) Functional recovery (time course: a, e, i,
m; recovery index: b, f, j, n) and whisker pad reinnervation determined
by counting retrogradely labelled Fluorogold-fluorescing facial moto-
neurons (FG+) 30 days after axotomy (c, g, k, o) in JunAA (a–d), JNK1
null (e–h), JNK2 null (i–l) and JNK3 null (m–p) mutants (KO) and their
wild-type counterparts (WT). (d, h, l, p) Axotomized (ax)/control (co)
side ratio – percent reinnervation – for the FG+ motoneurons. Overall,
there was very little effect for junAA (n = 23 mutants and 17 control
animals) and JNK2 (n = 30 mutants and 17 controls), but deletion of
JNK1 (n = 7 mutants and 9 controls) or JNK3 (n = 18 mutants and 12
controls) was associated with reduced functional recovery (e, f, m).
However, none of the four mutants showed an effect on the anatomical
reinnervation of the whisker pad at 30 days after facial nerve cut,
detected using Fluorogold retrograde labelling (third and fourth col-
umn, n = 7/7, 9/10, 6/5 and 6/9 for the junAA, JNK1, JNK2 and JNK3
null mutants and their controls, respectively. *p < 0.05 in unpaired t-
test. In panels (a, e, i and m), the significance levels were adjusted for
multiple testing using Bonferroni correction. Filled bars in the third
column (c, g, k and o) show FG+ motoneuron number on the control,
contralateral side, and empty bars the axotomized side in the same
group of animals. In all other graphs, filled bars or circles represent
wild-type, and empty bars, mutant animals.
 2012 The Authors
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increase in nutrient transport, metabolism and cytoskeletal
protein synthesis (Makwana and Raivich 2005, Raivich and
Makwana 2007). As animals for the day 4 time point were
used for speed of regeneration experiment in the crushed
facial nerve (Fig. 4), the day 4 facial motor nucleus data are
following nerve crush; the day 14 data are following cut.
As shown in left upper part of Fig. 5, axotomy of the facial
nerve in the junF/F control animals causes an increase in the
immunoreactivity for the adhesion molecules CD44 (Fig. 5a
and b) and the beta1 integrin subunit (Fig. 5e and f),
neuropeptides CGRP (Fig. 5i and j) and galanin (Fig. 5m
and n) and the ATF3 transcription factor (Fig. 5q and r).
These axotomy-induced changes are decreased or even, as in
the case of CD44, completely abolished in the junDS mice
(Fig. 5c,d,g,h,k,l,o,p,,s and t). Direct quantification of immu-
noreactivity in Fig. 6 revealed a significant decrease
(p < 0.05) in the amount of immunoreactivity on the
axotomized side in the junDS mouse mutants compared with
junF/F controls (Fig. 6a,b,g,h,m,n,s,t,y and ad), as well as a
smaller (Fig. 6a,b,h,n,s and y) or even no increase (Fig. 6g,m
and t) of the immunoreactivity from the control to the
axotomized side, on average, junDS mice showed an up to
80–100% smaller increase 4 days after facial nerve crush, or
14 days after nerve cut. To determine, whether these changes
depend on c-Jun phosphorylation, we next examined changes
in CD44, CGRP and ATF3 immunoreactivity in the JNK1, 2
and 3 knockouts and the JunAA mutants at 4 days after nerve
crush and 14 days after facial nerve cut. Compared with their
controls, JunAA and JNK3 null mutants showed a significant
but moderate reduction in CD44 immunoreactivity, at one of
the two tested time points – Fig. 6f ()24%), and Fig. 6k
()37%), respectively, for the axotomized to control side
difference. The CGRP levels in the case of JNK3 also ATF3
levels were not affected. Deletion of JNK1 (Fig. 6c,i,o,u,z
and ae,) or JNK2 (Fig. 6d,j,p,v,aa and af,) had no effect on
one of the three tested immunohistochemical neuronal
injury-associated markers.
As shown in the Supplementary materials, very similar
results – massive inhibition in case of neuronal c-Jun
deletion, but at most just moderate effects following deletion
of JNK1 or JNK3, or in the junAA mutants were also
observed for glial activation and for recruitment of T cells
into the facial motor nucleus (Figures S2 and S3).
Discussion
The present data confirm the essential role of neuronal c-Jun
for the ability of injured neurons to regenerate following
axonal disconnection. Removal of the loxP targeted (floxed)
jun gene with cre recombinase under the control of a neuron-
specific synapsin promoter abolished basal and injury-
induced neuronal c-Jun immunoreactivity, as well as most
of the molecular response following facial axotomy. This
absence of neuronal Jun strongly reduced the speed of axonal
regeneration following crush, prevented the vast majority of
transected axons after cut from reconnecting to their
peripheral target, and impaired functional recovery. Despite
blocking neuronal cell death, this was also associated with a
large number of shrunken neurons. Finally, junDS mutants
also had diminished astrocyte and microglial activation and
T-cell influx, demonstrating that this non-neuronal response
depends on the release of Jun-dependent signals from
neighboring injured motoneurons.
Compared with complete jun gene excision in neurons, the
effects of removing serine 63 and 73 phosphoacceptor sites
(junAA), or of global deletion of individual kinases respon-
sible for N-terminal c-Jun phosphorylation were mild. The
reason global JNK null or junAA mutants were used, because
unlike the case with floxed c-Jun, only global mutants were
available, and because our primary question was whether the
regeneration effects of c-Jun could be reproduced by
interfering with its N-terminal phosphorylation. Interestingly,
the junAA mutants showed decrease in neuronal cell size, a
very moderate reduction in post-axotomy CD44 levels and
slightly increased astrogliosis. Deletion of JNK1 or JNK3
showed reduced functional recovery; deletion of JNK3 also
interfered with T-cell influx, and somewhat reduced CD44
levels. Deletion of JNK2 had no effect. Thus, neuronal c-Jun
is needed in regeneration, but most of this activity may not
Fig. 4 Facial nerve regeneration relies on the presence of neuronal c-
Jun. Longitudinal outgrowth of fastest CGRP- and galanin-immuno-
reactive axons in mm below the crush site, 4 days after facial nerve
injury. (a–e) Effects of junDS (a, n = 6 control junF/F and 4 junDS
animals), junAA (b, n = 5 control and 4 mutant mice) and JNK1 (c,
n = 7 controls and 4 null mutant mice), JNK2 (d, n = 2 controls and 3
null mutant mice) and JNK3 (e, n = 5 controls and 5 null mutant mice).
Note the very similar outgrowth distances for the CGRP- and galanin-
immunoreactive axons. JunDS deletion caused a 65–70% decrease in
neurite outgrowth, all other mutations had no significant effect.
*p < 0.05 in unpaired t-test. Only sections stained for CGRP immu-
noreactivity were available for junAA and its controls.
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require the presence of individual JNKs or that of the 63 and
73 acceptor sites.
Although cell-type selective excision of target genes is
now standard tool in identifying cell-specific function, this
can lead to problems if the promoter used to drive cre
recombinase is too broad. For example, the nestin promoter
used in brain-wide jun deletion is expressed in early
neuroepithelial cells giving rise to neurons, but also to
astrocytes or oligodendroglia. Outside the brain, nestin
expression is also found in the islet, liver and muscle stem
cells, as well as in Schwann cell precursors (Rao 1999;
Akiyama et al. 2001; Kanu et al. 2010), raising the question
whether the regeneration differences observed in that study
were also due to jun deletion in other cells of neuroepithelial
origin. Schwann cells strongly up-regulate c-Jun following
axotomy, and removal of Schwann cell c-Jun (Parkinson
et al. 2008) has recently been shown to interfere with axonal
regeneration. This problem is resolved in the present study
because synapsin promoter expression is highly restricted,
limited to the testis and to maturing and mature neurons in
the CNS and peripheral ganglia (Hoesche et al. 1993; Street
et al. 2005).
In the currently used facial axotomy model, deletion of
neuronal c-Jun produces four sets of effects: it interferes with
the expression of numerous target genes involved in
molecular changes after facial nerve axotomy, it impairs
the flow of activation and recruitment signals to neighboring
non-neuronal cells, it abolishes regenerative capacity in most
neurons, and it promotes the survival of shrunken and
probably still axotomized neuronal cell bodies. Peripheral
nerve cut and crush injuries sometimes elicit differing
responses at the level of neuronal cell body (Bareyre et al.
(a) (b) (c) (d)
(e) (f) (g) (h)
(i) (j) (k) (l)
(m) (n) (o) (p)
(q) (r) (s) (t)
Fig. 5 Biochemical components of neuronal axotomy response de-
pend on the presence of c-Jun. (a–t) Facial nucleus axotomy response
14 days after nerve cut in the junF/F controls (a, b, e, f, i, j, m, n, q, r)
and the junDS mutant (c, d, g, h, k, l, o, p, s, t) mice. Contralateral side
(co) -first and third column, Axotomized side (ax) – second and fourth
column. After axotomy, junF/F mice show a prominent increase in
adhesion molecules CD44 (a–d) and beta1-integrin subunit (e–h),
neuropeptides CGRP (i–l) and galanin (m–p) and TF ATF3 (q–t); these
changes are reduced or abolished in the junDS mutants. Scale bar
0.2 mm.
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2011), but in the current case, the molecular responses
studied were strongly affected by both types of axotomy, and
this response reduced in the absence of c-Jun. Overall, Jun-
dependent molecular changes in injured neurons appear
pivotal for the latter three sets of functional effects. In the
case of axonal regeneration, alpha7beta1 integrin, CD44,
galanin and ATF3 have been shown to play an important role
in neurite outgrowth. Deletion of the alpha7 integrin gene
retards axonal regeneration by 35–40% (Werner et al. 2000),
removal of the galanin gene delayed sensory functional
recovery (Sachs et al. 2007); and antibody inhibition of
CD44 reduces neurite outgrowth of transplanted central
noradrenergic neurons (Nagy et al. 1998) as well as creating
multiple errors in retinal axonal growth trajectory through the
optic chiasm (Lin and Chan 2003). Over-expression of ATF3
also speeds up the initiation of axonal outgrowth, involved in
the in vivo conditioning response (Seijffers et al. 2007). In all
four target genes, enhanced expression after injury depends
on the presence of neuronal c-Jun. CD44, a7 and galanin
have previously described AP1 consensus binding sequences
(Lee et al. 1993; Nishida et al. 1997; Anouar et al. 1999)
and ATF3 has been identified as a downstream target of
c-Jun (Mei et al. 2008). Neuronal p53, cathepsinB and noxA
have been implicated in axotomy-induced cell death (Kiryu-
Seo et al. 2005; Sun et al. 2010; Tedeschi and Di Giovanni
2009), and axotomy-induced chemokines including fractal-
kine and monocyte chemotactant protein (MCP)1 (Harrison
et al. 1998; Flu¨gel et al. 2001; Schreiber et al. 2001) could
contribute to non-neuronal recruitment and activation; here
the extent of Jun-dependence for the effects of these signals
will need to be demonstrated in future studies.
Previous studies revealed that activation of the c-Jun-
mediated transcriptional apparatus is affected by interactions
at three major sites: (i) N-Terminal phosphorylation at serine
Fig. 6 Effects of neuronal deletion of jun (junDS, a, b, g, h, m, n, s, t, y,
ad, first and second column), the global deletion of JNK1 (c, i, o, u, z, ae,
third column), JNK2 (d, j, p, v, aa, af, fourth column), and JNK3 (e, k, q,
w, ab, ag, fifth column), and of the junAA mutation (f, l, r, x, ac, ah, sixth
column) on changes in neuronal markers following axotomy. Quantifi-
cation of overall facial motor nucleus immunoreactivity for galanin (a, g)
and beta 1 integrin (m, s), CD44 (b–f and h–l), CGRP (n–r and t–x) and
ATF3 (y–ah) using OLV units. To facilitate finding the staining and time
point on the graph, the row labels (second column, top right of each
graph) are the same for the graphs in the third to sixth column). (a–e,
m–r, y–ac) 4 days after facial nerve crush, (g–l, s–x, ad–ah) 14 days
after facial nerve cut. Filled bars: contralateral (co), empty bars: axo-
tomized (ax) facial nucleus. In each graph, the first two bars represent
the data for control animals (wild-type or junF/F) and the third and fourth
bar those for the mutant ones. *p < 0.05 (unpaired t-test) for the dif-
ference on the axotomized side between the mutant and control group.
p < 0.05 (unpaired t-test) for the difference in immunostaining increase
due to axotomy (staining intensity on the control side subtracted from
that on the axotomized side) between the respective mutant and the
wild-type or junF/F control group. n = 3–7 animals per group, in each
control, and in each mutant group. All five tested markers – galanin,
beta1 integrin, CD44, CGRP and ATF3 showed significantly smaller
increase or even (g, m, t) the absence of increase, in the junDSmutants
compared with junF/F controls, at both time points – day 4 and day 14.
There was no effect for JNK1 or JNK2, and significant but slight de-
crease for CD44 at day 14 for JNK3 null and at day 4 for junAA.
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63 and 73 and threonine 91 and 93 (Smeal et al. 1994;
Morton et al. 2003), (ii) dephosphorylation of threonine 239
involved in the ubiquitination and removal of c-Jun (Morton
et al. 2003) and (iii) C-terminal lysine acetylation near
aa257–276 via p300 (Vries et al. 2001; also see Raivich 2008
for a review of the signalling pathways involved in the
activation of these Jun-domains). In the case of N-terminal
phosphorylation, axonal injury is associated with retrograde
transport of phosphorylated JNK, the upstream kinases
{[Mitogen-activated protein (MAP)] kinase kinase (MEK or
MKK)} kinase (MEKK)1 and phospho - MKK4, as well as
the JNK-interacting protein, a scaffold protein that stabilises
the interaction between JNK and its upstream kinases
(Lindwall and Kanje 2005a,b). Moreover, phosphorylation
of Jun will improve dimer stability and thus affect its
biological role in the nervous system. Substitution of JNK
phosphorylation motifs with those for protein kinase A (PKA)
abolishes c-Jun-mediated JNK effects (Smeal et al. 1994).
Replacement of the serine 63 and 73 phosphoacceptor sites in
the junAA mice prevents kainic acid excitotoxity (Behrens
et al. 1999), to a similar extent as global JNK3 deletion (Yang
et al. 1997; Brecht et al. 2005). Although JNKs have no
effect on retinal photoreceptor apoptosis (Grimm et al. 2001),
junAA and JNK3 null mutants show better neuronal survival
after targeted dopaminergic cell death (Brecht et al. 2005).
Complete JNK ablation – either by deletion or inhibition – has
also been shown to decreased caspase-dependent neuronal
cell death in both neuronal and non-neuronal cells (Weston
and Davis 2007).
Importantly, not all effects of JNK deletion need to be
mediated through N-terminal phosphorylation of Jun, and
thus would not be observed in the case of junAA – in the
current study, this primarily concerns the speed of functional
recovery which is normal in junAA, but reduced in JNK1
and 3 null mutations. Interestingly, deletion of JNK3 also
strongly reduces cell death of neonatal facial motor neurons
after nerve cut, but does not interfere with up-regulation of c-
Jun or the phosphorylation of the serine 63 and 73 residues
(Keramaris et al. 2005). In parentheses, single deletions of
JNK2 or 3 significantly decreased cell death in neonatal
models (Keramaris et al. 2005); as shown in the current
study, this effect was not observed following adult axotomy
in animals lacking JNK1, 2 or 3 (or the serine 63 and 73
phosphorylation sites), pointing to differences in molecular
mechanisms involved in neonatal and adult post-axotomy
cell death. So far more than 50 proteins have been shown to
be substrates for JNK (Bogoyevitch and Kobe 2006),
including various transcription factors in addition to c-Jun
(e.g. ATF2, E twenty-six (ETS)-like transcription factor
(ELK)1, p53, STAT1/3, etc.), nuclear hormone receptors,
apoptosis-regulating bcl2 family members, and signalling
and structural molecules involved in cell movement and
process outgrowth such as MAP2 (Bjo¨rkblom et al. 2005),
MAP1b (Barnat et al. 2010) and stathmin (Westerlund et al.
2011). Nuclear JNK localization is a requirement for JNK-
mediated cell death (Bjo¨rkblom et al. 2008) but effects on
neurite outgrowth can be mediated by JNK phosphorylation
of cytoplasmic targets (Bjo¨rkblom et al. 2005; Barnat et al.
2010; Westerlund et al. 2011).
With regards to neurite outgrowth, global in vitro inhibition
of JNK1/2 and 3 with 10 lM SP600125 strongly reduces and
at 200 lM completely blocks outgrowth from the sensory
nodose ganglion and dorsal root neurons (Lindwall et al.
2004; see also Barnat et al. 2010), as well as from sympa-
thetic neurons (Lindwall and Kanje 2005a). In vitro studies
also showed that deletion of JNK2 or JNK3 interferes with
initial dorsal root ganglia (DRG) neurite outgrowth, and
deletion of JNK1 and particularly of JNK2 with neurite
length. It is possible that combined deletion of all 3 JNKs
would have a more pronounced effect, but unfortunately
combined deletion of JNK1 and 2 or of all 3 JNKs is
embryonic lethal (Kuan et al. 1999; Sabapathy et al. 1999).
Interestingly, functional recovery was not affected in junAA
mice (Fig. 3a), suggesting the better performance in the JNK1
and 3 wild-type animals could be due to extra-Jun effects of
the JNKs. The regeneration effects shown in the current study
in Fig. 3e–p were moderate, with deletions of JNK1 or JNK3
reducing functional recovery, but not interfering with the
extent of reinnervation 50 days after facial nerve cut.
In the cerebellar granule cell neurons, inhibition of JNK
with 10 uM SP600125, or of the more upstream JNK
pathway with mixed lineage kinase inhibitor CEP11004
blocks the ATF3 up-regulation and the ATF3/Phospho-c-Jun
mediated cell death following potassium deprivation (Mei
et al. 2008). However in the current study, deletion of
JNK1,2 or 3, or the junAA mutation had no effect on the
post-axotomy increase in ATF3 (Fig. 6y–ah), or on neuronal
cell death (supplementary Fig. 1). Interestingly, although the
junAA mutation did not reduce the cell death it did enhance
cell shrinkage. This could suggest that N-terminal phosphor-
ylation brought about through retrograde transport of the
kinases (Lindwall and Kanje 2005b) may be important in
maintaining the trophic state of surviving neurons. Theoret-
ically, activated JNKs will also lead to the phosphorylation
of threonine 91 and 93, which depends on the presence of
negatively charged phospho-threonine 95, a target of ataxia
teleangiectasia mutated kinase but not of JNK (Vinciguerra
et al. 2008). Acting in concert, phosphorylation of the three
threonines will enhance cell death in response to DNA
damage (Vinciguerra et al. 2008). Because the three Thr
residues are still present in junAA, a similar mechanism may
be involved in responsible for reduced functional recovery in
the JNK1 or JNK3 null mutants, but not in the junAA mice.
Preliminary data using mutant jun4A mice where all 4 JNK-
dependent sites were replaced by alanines (S. Patodia,
G. Raivich and A. Behrens, unpublished data), do show
similar neuronal shrinkage as in junAA, but in addition a
moderate but significant decrease in functional recovery (as
 2012 The Authors
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with JNK1 or JNK3 deletions) as well as an approximately
40% reduction in whisker pad target reinnervation 30 days
after facial nerve cut. Nevertheless, this reinnervation effect
is 3–4 times smaller in magnitude than that observed
following neuronal deletion of c-Jun (Fig. 2e and f).
It is possible that removal of all 4 phosphoacceptor sites is
also needed to reproduce the massive reduction in T-cell
influx in the JNK3 null mutants 14 days after facial nerve
cut, a peak phase in neuronal cell death, microglial
phagocytosis and lymphocyte recruitment (Raivich et al.
1998), but this would need to be ascertained in future studies.
What the current study does is that it confirms that the pro-
regeneration, pro-inflammatory and pro-cell death c-Jun
effects observed with nestin-promoter driven expression of
Cre recombinase are indeed due to to the neuronal expression
of c-Jun. By comparison, the JNK phosphorylation of the
N-terminus mostly appears to not be required for these
functions.
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